JP2001505768A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001505768A5 JP2001505768A5 JP1998524475A JP52447598A JP2001505768A5 JP 2001505768 A5 JP2001505768 A5 JP 2001505768A5 JP 1998524475 A JP1998524475 A JP 1998524475A JP 52447598 A JP52447598 A JP 52447598A JP 2001505768 A5 JP2001505768 A5 JP 2001505768A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75642996A | 1996-11-26 | 1996-11-26 | |
| US08/756,429 | 1996-11-26 | ||
| PCT/IB1997/001482 WO1998023755A1 (en) | 1996-11-26 | 1997-11-26 | Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2001505768A JP2001505768A (ja) | 2001-05-08 |
| JP2001505768A5 true JP2001505768A5 (enExample) | 2004-10-28 |
| JP4226657B2 JP4226657B2 (ja) | 2009-02-18 |
Family
ID=25043444
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP52447598A Expired - Lifetime JP4226657B2 (ja) | 1996-11-26 | 1997-11-26 | 診断、予防、及び治療のための、多発性硬化症に関連するウイルス性物質及びヌクレオチド断片 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US6582703B2 (enExample) |
| EP (1) | EP0942987B1 (enExample) |
| JP (1) | JP4226657B2 (enExample) |
| AT (1) | ATE440141T1 (enExample) |
| CA (1) | CA2272845C (enExample) |
| DE (1) | DE69739544D1 (enExample) |
| ES (1) | ES2331496T3 (enExample) |
| WO (1) | WO1998023755A1 (enExample) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0942987B1 (en) * | 1996-11-26 | 2009-08-19 | Bio Merieux | Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes |
| US20040176314A1 (en) * | 1997-07-07 | 2004-09-09 | Bio Merieux | Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders |
| FR2765588A1 (fr) * | 1997-07-07 | 1999-01-08 | Bio Merieux | Materiel nucleique retroviral et fragments nucleotidiques notamment associes a la sclerose en plaques et/ou la polyarthrite rhumatoide, a des fins de diagnostic, prophylactiques et therapeutiques |
| DE19814925C2 (de) * | 1998-04-03 | 2000-10-05 | Thomas Harrer | Arzneimittel zur Induktion zytotoxischer T-Zellen |
| FR2780069B1 (fr) * | 1998-06-23 | 2002-06-28 | Inst Nat Sante Rech Med | Famille de sequences nucleiques et de sequences proteiques deduites presentant des motifs retroviraux endogenes humains et leurs applications |
| FR2788784A1 (fr) * | 1999-01-21 | 2000-07-28 | Bio Merieux | Fragment nucleique endogene associe a une maladie auto-immune, procede de marquage et reactif |
| EP1029917A1 (en) * | 1999-02-15 | 2000-08-23 | Bio Merieux | The LTR region of MSRV-1 and the proteins it encodes, and probes and methods for detecting MSRV-1 retrovirus |
| DE19921419A1 (de) | 1999-05-08 | 2000-11-16 | Univ Ruprecht Karls Heidelberg | Verfahren zum spezifischen Nachweis und zur Identifizierung retroviraler Nukleinsäuren / Retroviren in einem Untersuchungsgut |
| WO2001014564A2 (en) * | 1999-08-20 | 2001-03-01 | Curagen Corporation | Polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby |
| FR2805279B1 (fr) * | 2000-02-23 | 2004-09-24 | Jean Jacques Guilhou | Sequences retrovirales associees a des affections cutanees |
| US7774144B2 (en) * | 2001-10-26 | 2010-08-10 | Samuel Bogoch | System and method for identifying complex patterns of amino acids |
| NZ592340A (en) * | 2001-03-27 | 2012-12-21 | Elenore S Bogoch | A method for making a virus vaccine compising Replikin peptides |
| US7442761B2 (en) * | 2003-06-06 | 2008-10-28 | Samuel Bogoch | Replikin peptides and uses thereof |
| US7452963B2 (en) * | 2001-03-27 | 2008-11-18 | Samuel Bogoch | Replikin peptides and antibodies therefore |
| US7189800B2 (en) * | 2001-03-27 | 2007-03-13 | Samuel Bogoch | Replikin peptides in rapid replication of glioma cells and in influenza epidemics |
| US8494781B2 (en) * | 2003-06-06 | 2013-07-23 | Samuel Bogoch | Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds |
| FR2863274B1 (fr) * | 2003-12-05 | 2012-11-16 | Commissariat Energie Atomique | Procede d'evaluation quantitative d'un rearrangement ou d'une recombinaison genetique ciblee d'un individu et ses applications. |
| US9254315B2 (en) * | 2004-04-28 | 2016-02-09 | Samuel Bogoch | Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds |
| EP2027146B1 (en) * | 2006-05-30 | 2012-10-03 | Bogoch, Samuel, Dr. | Replikin peptides and uses thereof |
| WO2008143717A2 (en) * | 2007-01-18 | 2008-11-27 | Samuel Bogoch | Methods of determining lethality of pathogens and malignancies involving replikin peak genes |
| US20090269367A1 (en) * | 2008-04-23 | 2009-10-29 | Samuel Bogoch | Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles |
| US20100144589A1 (en) * | 2008-08-08 | 2010-06-10 | Samuel Bogoch | Methods of predicting cancer lethality using replikin counts |
| US8680065B2 (en) * | 2008-09-11 | 2014-03-25 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Oligonucleotides of human endogenous retrovirus 9 (ERV-9) long terminal repeat (LTR) and methods of use |
| US9233148B2 (en) * | 2009-01-09 | 2016-01-12 | Samuel Bogoch | Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza |
| FR2984364A1 (fr) * | 2011-12-20 | 2013-06-21 | Biomerieux Sa | Procede pour le diagnostic ou le pronostic in vitro du cancer de l'ovaire |
| FR2984360B1 (fr) * | 2011-12-20 | 2017-11-24 | Biomerieux Sa | Procede pour le diagnostic ou le pronostic in vitro du cancer du colon |
| US10253353B2 (en) * | 2013-12-06 | 2019-04-09 | The Broad Institute, Inc. | Enhanced methods of ribonucleic acid hybridization |
| GB201509395D0 (en) * | 2015-06-01 | 2015-07-15 | Univ Leicester | Improvements in and relating to nucleic acid probes |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ191327A (en) | 1978-08-24 | 1981-07-13 | W B Martin | Pasteurellosis vaccine comprising antigenic material derived from the a1 and a2 serotypes of pasteurella haemolytica |
| US4311686A (en) | 1979-04-30 | 1982-01-19 | The Immunology Development Corporation | Methodology for the immunodiagnosis of multiple sclerosis and/or malignant diseases from blood sample analysis |
| US4396600A (en) | 1980-12-18 | 1983-08-02 | Gus Gallucci | Adult schistosome worm-derived antigenic substance and method of obtaining same |
| US4388298A (en) | 1982-07-14 | 1983-06-14 | The United States Of America As Represented By The Secretary Of Agriculture | Propagation of hemorrhagic enteritis virus in a turkey cell line and vaccine produced |
| GB8324800D0 (en) | 1983-09-15 | 1983-10-19 | Pasteur Institut | Antigens |
| US4520113A (en) | 1984-04-23 | 1985-05-28 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Serological detection of antibodies to HTLV-III in sera of patients with AIDS and pre-AIDS conditions |
| US4647773A (en) | 1984-04-23 | 1987-03-03 | The United States Of America As Represented By The Department Of Health And Human Services | Method of continuous production of retroviruses (HTLV-III) from patients with AIDS and pre-AIDS |
| NZ218050A (en) | 1985-11-13 | 1989-05-29 | Wistar Inst | Test for the presence of htlv-1v |
| US4900553A (en) | 1987-09-11 | 1990-02-13 | Case Western Reserve University | Method of reducing glial scar formation and promoting axon and blood vessel growth and/or regeneration through the use of activated immature astrocytes |
| EP0326395A2 (en) | 1988-01-29 | 1989-08-02 | City Of Hope | Method of detecting and identifying certain viral sequences |
| FR2651581B1 (fr) | 1989-09-06 | 1994-05-13 | Centre Nal Recherc Scientifique | Moyens pour le diagnostic de neuropathies demyelinisantes, en particulier de la sclerose en plaques. |
| US5219837A (en) | 1990-06-21 | 1993-06-15 | Trustees Of The University Of Pennsylvania | Method of stimulating myelination of cells |
| US5158976A (en) | 1990-10-29 | 1992-10-27 | The Children's Medical Center Corporation | Controlling glutamine/glutamate related neuronal injury |
| DK173091D0 (da) | 1991-10-11 | 1991-10-11 | Schleroseforeningen The Danish | Biologisk materiale |
| FR2689520B1 (fr) | 1992-04-03 | 1996-07-19 | Bio Merieux | Procede et milieu de culture pour l'obtention de cellules infectees par un virus associe a la sclerose en plaques. |
| FR2689521B1 (fr) | 1992-04-03 | 1996-07-19 | Bio Merieux | Procede d'obtention et maintien d'une culture cellulaire viable, infectee par un virus associe a la sclerose en plaques, et produits biologiques derives de ladite culture. |
| EP0642585B1 (en) | 1992-05-18 | 2005-12-28 | Genentech, Inc. | Activation of oligomerizing receptors by using fused receptor ligands |
| GB9310657D0 (en) * | 1993-05-24 | 1993-07-07 | Univ London | Retrovirus |
| DE69533863T2 (de) | 1994-02-04 | 2006-02-16 | Bio Merieux | MSRV1 Virus der mit Multipler Sklerose verbunden ist, seine nukleären Bestandteile und Verwendungen |
| FR2716198B1 (fr) | 1994-02-15 | 1996-04-19 | Bio Merieux | Facteur cytotoxique tel qu'associé à la sclérose en plaques, sa détection et sa quantification. |
| FR2731356B1 (fr) * | 1995-03-09 | 1997-04-30 | Bio Merieux | Virus msrv-1 et agent pathogene et/ou infectant msrv-2 associes a la polyarthrite rhumatoide |
| FR2737500B1 (fr) * | 1995-08-03 | 1997-08-29 | Bio Merieux | Materiel viral et fragments nucleotidiques associes a la sclerose en plaques, a des fins de diagnostic, prophylactiques et therapeutiques |
| EP0942987B1 (en) * | 1996-11-26 | 2009-08-19 | Bio Merieux | Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes |
-
1997
- 1997-11-26 EP EP97911411A patent/EP0942987B1/en not_active Expired - Lifetime
- 1997-11-26 DE DE69739544T patent/DE69739544D1/de not_active Expired - Lifetime
- 1997-11-26 CA CA002272845A patent/CA2272845C/en not_active Expired - Lifetime
- 1997-11-26 US US08/979,847 patent/US6582703B2/en not_active Expired - Lifetime
- 1997-11-26 AT AT97911411T patent/ATE440141T1/de not_active IP Right Cessation
- 1997-11-26 WO PCT/IB1997/001482 patent/WO1998023755A1/en not_active Ceased
- 1997-11-26 ES ES97911411T patent/ES2331496T3/es not_active Expired - Lifetime
- 1997-11-26 JP JP52447598A patent/JP4226657B2/ja not_active Expired - Lifetime
-
2002
- 2002-04-03 US US10/114,104 patent/US20030198647A1/en not_active Abandoned
-
2006
- 2006-10-16 US US11/581,030 patent/US7674888B2/en not_active Expired - Lifetime